Randomized phase III trial in MMR deficient endometrial cancer patientscomparing chemotherapy alone versus Dostarlimab in first line advanced/metastatic setting: DOMENICA STUDY

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2024
This article has no abstract
Epistemonikos ID: 55311f61fa80ee65ae98b3abba7b23aa4a72b18e
First added on: Apr 11, 2025